TY  - JOUR 
AU  - Martinez-Lopez, Joaquin
AU  - Lahuerta, Juan José
AU  - Pepin, François
AU  - González Díaz, Marcos
AU  - Barrio, Santiago
AU  - Ayala, Rosa
AU  - Puig Morón, Noemí
AU  - Montalban, María A
AU  - Lourenço Paiva, Bruno
AU  - Weng, Li
AU  - Jimenez, Cristina
AU  - Sopena, María
AU  - Moorhead, Martin
AU  - Cedena, Teresa
AU  - Rapado, Immaculada
AU  - Mateos Manteca, María Victoria
AU  - Rosiñol, Laura
AU  - Oriol, Albert
AU  - Blanchard, María J
AU  - Martinez, Rafael
AU  - Bladé, Joan
AU  - San Miguel Izquierdo, Jesús Fernando
AU  - Faham, Malek
AU  - García Sanz, Ramón
PY  - 2014
UR  - http://hdl.handle.net/10366/155258
AB  - [EN]We assessed the prognostic value of minimal residual disease (MRD) detection in multiple myeloma (MM) patients using a sequencing-based platform in bone marrow samples from 133 MM patients in at least very good partial response (VGPR) after...
LA  - eng
PB  - American Society of Hematology
KW  - Myeloma
KW  - Deep sequencing
KW  - Next Generation Sequencing
KW  - Minimal Residual Disease
KW  - Prognosis
KW  - Aged
KW  - Bone Marrow
KW  - Multiple Myeloma
KW  - High-Throughput Nucleotide Sequencing
KW  - Adult
KW  - Humans
KW  - Cohort Studies
KW  - Middle Aged
TI  - Prognostic value of deep sequencing method for minimal residual disease detection in multiple myeloma
DO  - 10.1182/blood-2014-01-550020
T2  - Blood
VL  - 123
M2  - 3073
ER  -